Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma

Clinical trial NCT06257017 · RECRUITING

Trial details

NCT number: NCT06257017
Sponsor: Yung NA
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Muscle Invasive Bladder Urothelial Carcinoma Muscle-Invasive Bladder Carcinoma

Start date: 2024-02-02
Primary completion: 2025-09-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.